Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebrovascular Disease Small Vessel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00283959
What this trial is testing

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 4
Testing effectiveness (Phase 2)UnknownNCT00068913
What this trial is testing

Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

Who this might be right for
MELAS Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 35
Testing effectiveness (Phase 2)Study completedNCT02228460
What this trial is testing

Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 11
Not applicableUnknownNCT03230591
What this trial is testing

Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's Cardiomyopathy

Who this might be right for
Fabry Disease
Yonsei University 25
Large-scale testing (Phase 3)Study completedNCT03566017
What this trial is testing

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 97
Not applicableStudy completedNCT00001491
What this trial is testing

Analysis of the Nervous System in Patients With Fabry's Disease

Who this might be right for
Fabry's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 325
Not applicableNot Yet RecruitingNCT07250425
What this trial is testing

Development and Efficacy of a Novel, Cost-Effective Gait Training Device Utilized at Home for Stroke Survivors

Who this might be right for
StrokeNeurological Diseases or ConditionsHemiparesis;Poststroke/CVA+8 more
Healing Innovations 20
Not applicableLooking for participantsNCT06031610
What this trial is testing

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

Who this might be right for
Carotid Artery StenosisCerebral Small Vessel Diseases
Zhejiang Provincial People's Hospital 1,000
Early research (Phase 1)Study completedNCT02544217
What this trial is testing

A Dose-escalating Clinical Trial With KH176

Who this might be right for
MELASLHONLeigh Syndrome+2 more
Khondrion BV 32
Post-approval studies (Phase 4)Study completedNCT05054387
What this trial is testing

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 22
Not applicableLooking for participantsNCT07497867
What this trial is testing

Long-term Prospective Study of Korean CADASIL Patients

Who this might be right for
CADASILCerebral Autosomal Dominant Arteriopatie With Subcortical Infarcts and Leukoencephalopathy
Jeju National University Hospital 500
Large-scale testing (Phase 3)Study completedNCT01697267
What this trial is testing

Rituximab Vasculitis Maintenance Study

Who this might be right for
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMicroscopic PolyangiitisWegener Granulomatosis
Cambridge University Hospitals NHS Foundation Trust 188
Not applicableUnknownNCT06248892
What this trial is testing

The Effect of Oral and Nasal Feeding on Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel Diseases
Zeng Changhao 88
Testing effectiveness (Phase 2)Study completedNCT00071877
What this trial is testing

An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25
Large-scale testing (Phase 3)Study completedNCT00925301
What this trial is testing

Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 67
Large-scale testing (Phase 3)Active Not RecruitingNCT05206773
What this trial is testing

Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease

Who this might be right for
Fabry Disease
Sanofi 122
Not applicableEnrolling By InvitationNCT07560956
What this trial is testing

Quality of Life in Adults With Untreated Fabry Disease in Sweden (QoLUF)

Who this might be right for
Fabry Disease
Vastra Gotaland Region 35
Post-approval studies (Phase 4)Looking for participantsNCT07087912
What this trial is testing

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital 477
Large-scale testing (Phase 3)Ended earlyNCT01458119
What this trial is testing

Open-Label Phase 3 Long-Term Safety Study of Migalastat

Who this might be right for
Fabry Disease
Amicus Therapeutics 85
Not applicableUnknownNCT06265857
What this trial is testing

Effect of Multifunctional Nutrition Tube on Cerebral Small Vessel Disease Patients

Who this might be right for
Cerebral Small Vessel DiseasesDysphagia
Zeng Changhao 88
Next Page